Key Segmentation
By Product Type
-
Reagents & Kits
-
Detergents (Solvent/Detergent Systems)
-
pH Adjustment Solutions
-
Pathogen Reduction Systems
-
Other Consumables
By Method
-
Solvent/Detergent (S/D) Inactivation
-
Heat Treatment (Pasteurization)
-
Low pH Inactivation
-
Others
By Application
-
Monoclonal Antibody Production
-
Vaccines
-
Blood & Plasma Derivatives
-
Recombinant Proteins
-
Others
By End-User
-
Pharmaceutical & Biopharmaceutical Companies
-
Contract Manufacturing Organizations (CMOs/CDMOs)
-
Research Institutes & Academic Labs
-
Blood Banks & Plasma Fractionation Centers
By Scale of Operation
-
Preclinical & R&D Scale
-
Clinical Scale
-
Commercial Manufacturing Scale
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
UK
-
France
-
Italy
-
Spain
-
Russia
-
Poland
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
North America dominated the Viral Inactivation Market in 2025.
The Reagents & Kits segment dominated the Viral Inactivation Market in 2025.
Rapid expansion of biologics, including monoclonal antibodies, vaccines, and advanced therapeutics, is the primary growth driver of the Viral Inactivation Market.
The Viral Inactivation Market was valued at USD 0.72 billion in 2025.
The Viral Inactivation Market is expected to grow at a CAGR of 12.30% from 2026 to 2035.